EE360 Clinical and Economic Evaluation of Atezolizumab Versus Durvalumab Administration in Adult Patients with Extensive Stage Small Cell Lung Cancer

Abstract

Authors

E. Makarova I. Krysanov V. Ermakova D.V. Kurkin

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×